Cargando…
Upregulation of Cyclooxygenase-2/Prostaglandin E(2) (COX-2/PGE(2)) Pathway Member Multiple Drug Resistance-Associated Protein 4 (MRP4) and Downregulation of Prostaglandin Transporter (PGT) and 15-Prostaglandin Dehydrogenase (15-PGDH) in Triple-Negative Breast Cancer
Elevated levels of cyclooxygenase-2 (COX-2) and prostaglandin E(2) (PGE(2)) are indicators of a poor prognosis in breast cancer. Using several independent publicly available breast cancer gene expression databases, we investigated other members of the PGE(2) pathway. PGE(2) is produced by COX-2 and...
Autores principales: | Kochel, Tyler J., Goloubeva, Olga G., Fulton, Amy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881873/ https://www.ncbi.nlm.nih.gov/pubmed/27257388 http://dx.doi.org/10.4137/BCBCR.S38529 |
Ejemplares similares
-
Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer
por: Kochel, Tyler J, et al.
Publicado: (2016) -
15‐Hydroperoxy‐PGE(2): Intermediate in Mammalian and Algal Prostaglandin Biosynthesis
por: Jagusch, Hans, et al.
Publicado: (2019) -
Role of cyclooxygenase-2-mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming
por: Muraoka, Naoto, et al.
Publicado: (2019) -
Impacts of Cytosolic Phospholipase A2, 15-Prostaglandin Dehydrogenase, and Cyclooxygenase-2 Expressions on Tumor Progression in Colorectal Cancer
por: Lim, Sung Chul, et al.
Publicado: (2010) -
A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE(2)-mediated immunosuppression and inhibits breast cancer metastasis
por: Ma, Xinrong, et al.
Publicado: (2013)